FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects

Brunt, A.M.; Haviland, J.; Sydenham, M.; Al-hasso, A.; Bloomfield, D.; Chan, C.; Churn, M.; Cleator, S.; Coles, C.; Emson, M.; Goodman, A.; Griffin, C.; Harnett, A.; Hopwood, P.; Kirby, A.; Kirwan, C.; Morris, C.; Sawyer, E.; Somaiah, N.; Syndikus, I.; Wilcox, M.; Zotova, R.; Wheatley, D.; Bliss, J.; Yarnold, J.

Abstract

Meeting abstract.

Citation

Brunt, A., Haviland, J., Sydenham, M., Al-hasso, A., Bloomfield, D., Chan, C., …Yarnold, J. (2018). FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects. Radiotherapy and Oncology, 127(S1), S311 -S312. https://doi.org/10.1016/S0167-8140%2818%2930905-8

• Journal Article Type: Conference Paper
• Conference Name: ESTRO 37, April 20-24, 2018
• Conference Location: Barcelona, Spain
• Acceptance Date: Apr 1, 2018
• Publication Date: Apr 1, 2018
• Journal: Radiotherapy and Oncology
• Print ISSN: 0167-8140
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 127
• Issue: S1
• Pages: S311 -S312
• DOI: https://doi.org/10.1016/S0167-8140%2818%2930905-8
• Publisher URL: http://doi.org/10.1016/S0167-8140(18)30905-8